GENI fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
GENinCode Plc engages in the genetic risk assessment of cardiovascular disease. It provides predictive analysis of risk to a patient’s health based on their genes. It operates through the Spain, Italy, France, Germany, United Kingdom, and Rest of the World. The Rest of the World segment includes Chile, Sweden, Mexico, and Peru. The company was founded by Matthew Heaton Walls and Jordi Puig Gilberte on September 6, 2018 and is headquartered in Manchester, the United Kingdom.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
GENI has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company